The New England journal of medicine
-
Controlled Clinical Trial
Multitarget stool DNA testing for colorectal-cancer screening.
An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. ⋯ In asymptomatic persons at average risk for colorectal cancer, multitarget stool DNA testing detected significantly more cancers than did FIT but had more false positive results. (Funded by Exact Sciences; ClinicalTrials.gov number, NCT01397747.).
-
Review Historical Article
Pandemic preparedness and response--lessons from the H1N1 influenza of 2009.